The prevalence of gestational diabetes was 6.0 percent in 2016, with a slight increase seen from 2012 to 2016.
In recognition of National Diabetes Education Week, Endocrinology Advisor compiled a list of resources to assist clinicians when educating patients with diabetes about their condition.
A growing body of research highlights the important role of bone in glucose metabolism.
To understand the associations between exposure to gestational diabetes and the risk for maternal glucose metabolism and childhood adiposity, researchers followed a cohort of mothers and children for a median of 11.4 years.
These findings suggest an increased risk for postpartum depressive symptoms in mothers with gestational diabetes, independent of depressive symptomatology during pregnancy.
Untreated gestational diabetes is associated with development of subsequent glucose metabolism disorders in mothers, but is not significantly associated with the composite outcome of childhood overweight/obesity in long-term follow-up of offspring.
First-trimester HbA1c significantly improves GDM prediction compared with conventional risk factors.
Investigators sought to compare cardiovascular risk and disease prevalence in the Hispanic and Latina population in the United States with and without a history of gestational diabetes.
Modifiable pregnancy and postpartum factors associated with at least 75% of weight loss in postpartum women with gestational diabetes have been examined.
Uniform application of gestational diabetes diagnostic thresholds may not be appropriate in populations across the world.
Fetal genetic score for birth weight affects fetal growth at various maternal fasting plasma glucose levels.
This study demonstrated the importance of early screening and diagnosis of type 2 diabetes in mothers and their offspring.
Investigators developed a community-based pre-pregnancy care program to improve pregnancy outcomes.
Greater awareness of clinical and cost implications of gaps for patients with lower-severity gestational diabetes may improve postdelivery testing and referral.
A tailored electronic health record letter may improve gestational weight gain and reduce postpartum weight retention.
The researchers found that, compared with women without gestational diabetes or subsequent diabetes, women with a history of gestational diabetes had significantly higher estimated glomerular filtration rate.
Findings do not support noninferiority of glyburide for prevention of perinatal complications of gestational diabetes.
Results showed there was a significant crude risk linked to continuing vs discontinuing certain antipsychotics and developing gestational diabetes; for quetiapine the risk was 7.1% vs 4.1% (adjusted relative risk [ARR] 1.28), respectively; among olanzapine users it was 12% vs 4.7% (ARR 1.61), respectively.
Routine screening for neonatal hypoglycemia after pregnancies complicated by gestational diabetes (GD) reveals high incidence of both mild and severe hypoglycemia for both diet-controlled and insulin-treated GD and across the full range of birth weight centiles.
In this randomized controlled trial, glyburide was not noninferior in terms of the composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia compared with subcutaneous insulin.
Researchers assessed the associations of pre-pregnancy fitness, moderate-to-vigorous-intensity physical activity, and time spent watching television on subsequent development of gestational diabetes.
Parents and healthcare workers should carefully consider the risk for obesity in infants born to women with diabetes, especially infants born large for gestational age, and should initiate preventive measures where possible.
For women with previous gestational diabetes, lactation is associated with reduced risk of type 2 diabetes, although there is no benefit for long-term lactation.
High-quality studies are needed to determine whether tight intrapartum glycemic control is superior to more relaxed glycemic targets intrapartum for women with diabetes in pregnancy.
Ten randomized controlled trials were examined to determine the efficacy and safety of glyburide vs insulin treatment for gestational diabetes.
Hyperandrogenic PCOS is associated with maternal pregnancy complications, including gestational diabetes.
Special considerations are needed when treating women of reproductive age with pregestational diabetes.
Researchers examined the relationship between maternal diabetes and asthma risk in children.
Neonates did not differ in terms of birthweight, fat mass, body fat percentage, and sum of skinfolds, regardless of treatment.
One biomarker measurement during pregnancy can identify glucose intolerance with high sensitivity and specificity.
Endocrinology Advisor Articles
- Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes
- Measuring Time in Range During CGM May Be Useful Outcome Metric for Clinical Trials
- HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality
- Safety and Effectiveness of the Most Common Bariatric Procedures Examined
- AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D
- High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes
- Online Tool Helps Patients With Advance Care Planning
- Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes
- Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection
- Technological Breakthroughs in Medicine Move Physician-Patient Interactions From The Computer Screen Back to the Exam Room